Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Richard Adcock / ImmunityBio

Richard Adcock & ImmunityBio

2 shared events · Importance 3 · Last updated May 27, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
63
Regulatory
ImmunityBio Faces Securities Fraud Lawsuits
Richard Adcock: Richard Adcock is the CEO of ImmunityBio and was the recipient of the FDA's warning letter regarding the misleading promotion of Nogapendekin alfa inbakicept.
ImmunityBio: ImmunityBio is the defendant in multiple securities class action lawsuits due to alleged misleading statements about its drug Anktiva, which caused its stock price to fall significantly. The company faces investigations and potential financial penalties.
Apr 02, 2026 · 132 articles
0
Business
ImmunityBio Faces Anktiva Misrepresentation Lawsuits
Apr 01, 2026 · 64 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Richard Adcock and ImmunityBio interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.